RecruitingNCT07668687

European Multi-Centre Post-Market Registry on Thoracic Endovascular Arch Repair Using Castor™ and Cratos™

European Multi-Centre Castor™ and Cratos™ Branched Endovascular Arch Repair Registry

Sponsor

Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd

Enrollment

100 participants

Start Date

Sep 12, 2025

Study Type

OBSERVATIONAL

Conditions

Aneurysm of Aorta, Thoracic Dissection of Thoracic Aorta Dissection of Thoracic Descending Aorta Penetrating Aortic Ulcers (PAUs)Intramural Hematoma of the Thoracic Aorta Ulcer-like Projection (ULP)

Summary

The Castor™ and Cratos™ Branched Aortic Stent Graft Systems are medical devices designed for the minimally invasive endovascular treatment of thoracic aortic pathologies in the descending aorta. The goal of this multi-centre retrospective and prospective observational registry study is to capture the short-, medium- to long-term safety and performance data of how Castor™ and Cratos™ stent-grafts work in real-world settings (everyday medical practice). The aim is to study approximately 100 patients in European hospitals, with competitive enrollment.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Implantation with Castor™ stent graft and a medical device called Implantation with Cratos™ stent graft for people with aneurysm of aorta, thoracic, dissection of thoracic aorta, and other related conditions. The study is currently recruiting participants at 4 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEImplantation with Castor™ stent graft

Treatment of subjects diagnosed with thoracic aortic pathologies using the Castor™ Branched Aortic Stent-Graft and Delivery System. Follow up as per institutional standard of care.

DEVICEImplantation with Cratos™ stent graft

Treatment of subjects diagnosed with thoracic aortic pathologies using the Cratos™ Branched Aortic Stent-Graft and Delivery System. Follow up as per institutional standard of care.

Locations(4)

ASKLEPIOS Kliniken St. Georg

Hamburg, Germany

Universitätsklinikum Münster (UKM)

Münster, Germany

Hôpital de Sion

Sion, Switzerland

Universitätsspital Zürich (USZ)

Zurich, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07668687

Related Trials

A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta

NCT0707838322 locations

Ankura™ TAA Stent Graft System Post-Market Clinical Follow-up Study

NCT056395698 locations